|
|
|
|
|
|
|
|
 Thursday's market movers including ValiRx |
|
תאריך: 13/06/2013 06:52 - על ידי: bambaec - 70 צפיות - קטגוריה: שונים
The firm has agreed an expanded protocol for its first-in-man studies on VAL 201 - the drug candidate being developed for prostate cancer\nLON:BAO
|
|
תגובות... |
|
Related videos... |
|
|
|
|
|
|
|
|
|
|
עברית 
